Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TGF-beta anticorps (AA 200-390)

L’anticorps anti-TGF-beta Monoclonal Souris est utilisé pour la détection de TGF-beta dans des échantillons de Humain. Il a été validé pour IHC.
N° du produit ABIN7864527
639,45 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour TGF-beta anticorps (AA 200-390) (ABIN7864527)

Antigène

Voir toutes TGF-beta (TGFb) Anticorps
TGF-beta (TGFb)

Reactivité

  • 63
  • 53
  • 50
  • 27
  • 22
  • 22
  • 22
  • 18
  • 17
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 38
  • 24
  • 2
  • 2
Souris

Clonalité

  • 40
  • 26
Monoclonal

Conjugué

  • 25
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp TGF-beta est non-conjugé

Application

  • 24
  • 22
  • 16
  • 14
  • 13
  • 13
  • 13
  • 9
  • 6
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

TGFB-7240
  • Épitope

    • 16
    • 5
    • 2
    • 1
    AA 200-390

    Fonction

    TGF-beta (Transforming Growth Factor beta) Antibody

    Specificité

    This MAb recognizes TGF beta 1, 2 and 3. Three TGF≤s have been identified in mammals. TGF≤1, TGF≤2 and TGF≤3 are each synthesized as precursor proteins that are very similar in that each is cleaved to yield a 112 amino acid polypeptide that remains associated with the latent portion of the molecules. Biologically active TGF≤ requires dimerization of the monomers (usually homodimers) and release of the latent peptide portion. Overall, the mature region of the TGF≤3 protein has approximately 80 % identity to the mature region of both TGF≤1 and TGF≤2. However, the NH2 terminals or precursor regions of their molecules share only 27 % sequence identity. TGF≤ s inhibits the growth of epithelial cells and stimulate the growth of mesenchymal cells. 79oΩ

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment (around aa200-390) of human TGFB protein

    Isotype

    IgG2, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    TGF-beta (TGFb)

    Autre désignation

    TGF-beta

    Sujet

    ARVD, BSC 1 cell growth inhibitor, CED, Cetermin, Diaphyseal dysplasia 1 (DPD1), Glioblastoma derived T cell suppressor factor (G TSF), Latency-associated peptide (LAP), Polyergin, Transforming growth factor beta 1 (TGF beta1 or TGFB1), TGF beta2 (TGFB2), TGF beta3 (TGFB3), TGFbeta (TGFB)

    Salivary gland carcinoma

    Poids moléculaire

    13kDa

    ID gène

    7040, 645227

    UniProt

    P01137

    Pathways

    EGFR Signaling Pathway, Cellular Response to Molecule of Bacterial Origin, Stem Cell Maintenance, Glycosaminoglycan Metabolic Process, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus
Vous êtes ici:
Chat with us!